Osmoprep and Heart attack - a phase IV clinical study of FDA data

Summary:

Heart attack is reported as a side effect among people who take Osmoprep (sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Norvasc, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Heart attack when taking Osmoprep. It is created by eHealthMe based on reports of 404 people who have side effects when taking Osmoprep from the FDA, and is updated regularly.

What is Osmoprep?

Osmoprep has active ingredients of sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate. It is often used in colonoscopy abnormal. eHealthMe is studying from 416 Osmoprep users. Check the latest studies of Osmoprep.

What is Heart attack?

Heart attack is found to be associated with 2,512 drugs and 3,290 conditions by eHealthMe. Check the latest studies of Heart attack.

On Apr, 30, 2026

404 people reported to have side effects when taking Osmoprep.
Among them, 12 people (2.97%) have Heart attack.

Among these 12 people:

How long have people been on Osmoprep when they have Heart attack? *

What is the gender of people who have Heart attack when taking Osmoprep? *

female: 50 %
male: 50 %

What is the age of people who have Heart attack when taking Osmoprep? *

What are other drugs people take besides Osmoprep? *

What are other side effects people have besides Heart attack? *

Nausea And Vomiting: 4 people, 33.33%
Diarrhea: 4 people, 33.33%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 33.33%
Cardiogenic Shock (inadequate circulation of blood): 4 people, 33.33%
Dizziness: 4 people, 33.33%
Left Ventricular Dysfunction: 3 people, 25.00%
Jugular Vein Distension (overloaded jugular vein): 3 people, 25.00%
Hypokalemia (low potassium): 3 people, 25.00%
Hyperhidrosis (abnormally increased sweating): 3 people, 25.00%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 3 people, 25.00%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 25.00%
Anaesthesia: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Osmoprep and have Heart attack?

- Check whether Heart attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Osmoprep:

Osmoprep (416 reports)

Heart attack treatments and more:

Heart attack (266,142 reports)

How severe was Heart attack and when was it recovered:

Heart attack in Osmoprep

Expand to all the drugs that have ingredients of sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate:

Heart attack and drugs with ingredients of sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate (33 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Osmoprep:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heart attack:

Heart attack (2,512 drugs)

Browse all the conditions that are associated with Heart attack:

Heart attack (3,290 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate (the active ingredients of Osmoprep) and Osmoprep (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.